TREATMENT OF SARS-COV-2 INFECTION WITH A COMBINATION OF TARGETS

摘要

The invention provides a combination of a SARS-CoV-2 cellular entry receptor and a viral proliferation inhibitor for the treatment of a SARS-CoV-2 infection and combined pharmaceutical preparations and kit-in-parts.